previous compound ID: 1142 next compound
InChIKey: KBOPZPXVLCULAV-UHFFFAOYSA-N
SMILES: C1=CC(=C(C=C1N)C(=O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "B Kus" "D Rotin" "DY Thomas" "GW Carlile" "JW Hanrahan" "J Liao" "R Robert" "E Matthes" "J Goepp"

chemical graph of compound 1142





CID is 4075
synonyms found at PubChem are:
5-Aminosalicylic acid, Mesalazine, mesalamine, 5-Amino-2-hydroxybenzoic acid, 89-57-6, Pentasa, Claversal, Asacol, Canasa, Salofalk, Rowasa, 5-ASA, m-Aminosalicylic acid, Mesasal, Lialda, Fisalamine, Lixacol, Apriso, Benzoic acid, 5-amino-2-hydroxy-, p-Aminosalicylsaeure, Asacolitin, Mesalazina, Mesalazinum, sfRowasa, 5-amino-2-hydroxy-benzoic acid, Asacol HD, 5-Aminosalicylate, Mesalazinum [Latin], Pentacol, 5-Amino Salicylic Acid, 3-carboxy-4-hydroxyaniline, Mesalamine [USAN], Mesalazina [Spanish], p-Aminosalicylsaeure [German], 2-Hydroxy-5-aminobenzoic acid, Mesavancol, Mesacol, Mesavance, Mezavant, Iialda, Mesalazine MMX, SALICYLIC ACID, 5-AMINO-, Mezavant XL, UNII-4Q81I59GXC, NSC 38877, Mesalamine (USP), Pentasa (TN), Salofalk Granu-Stix, Apriso (TN), Asacol (TN), Canasa (TN), Lialda (TN), Rowasa (TN), 5-AS, CCRIS 7334, Mesalazine (JAN/INN), EINECS 201-919-1, BRN 2090421, AI3-15564, MLS001424012, 4Q81I59GXC, CHEBI:6775, 5-Aminosalicylic Acid, Purified, AJG-501, MAX-002, SPD-476, SPD-480, KBOPZPXVLCULAV-UHFFFAOYSA-N, mesalamine (USAN), Mesalamine HCl, MD-0901, CAS-89-57-6, NCGC00016344-03, SMR000145728, Z-206, DSSTox_CID_4506, DSSTox_RID_77435, DSSTox_GSID_24506, Asacolon, Ascolitin, Delzicol, Fivasa, 5 Aminosalicylate, 5-Aminosalicylicacid, m Aminosalicylic Acid, 5 Aminosalicylic Acid, Novo 5 ASA, Novo-5 ASA, meta Aminosalicylic Acid, meta-Aminosalicylic Acid, SR-01000763486, Hydrochloride, Mesalamine, Mesalamine [USAN:USP], Mesalamine Monosodium Salt, Monosodium Salt, Mesalamine, mesalsal, Salozinal, Asalit, Ipocol, HSDB 7512, minosalicylic acid, SPD 476, Mesalamine (TN), Delzicol (TN), Salofalk (TN), Sfrowasa (TN), Mesalazine [INN], Mesalazina[Spanish], Masacol (TN), Iialda (TN), Ipocal (TN), Mesalamine (Lialda), Novo5 ASA, 5-Aminosalicyclic acid, Meta-AminosalicylicAcid, 5-amino-salicylic acid, PubChem17623, Mesalamine|||Mesalazine, ACMC-1BKFR, Byk Brand of Mesalamine, AC1L1HCS, Falk Brand of Mesalamine, Prestwick0_001069, Prestwick1_001069, Prestwick2_001069, Prestwick3_001069, Axcan Brand of Mesalamine, WLN: ZR DQ CVQ, CHEMBL704, D0C4YC, Solvay Brand of Mesalamine, EC 201-919-1, Allphar Brand of Mesalamine, Antigen Brand of Mesalamine, cid_4075, Farmasa Brand of Mesalamine, Ferring Brand of Mesalamine, Merckle Brand of Mesalamine, Norgine Brand of Mesalamine, Celltech Brand of Mesalamine, Provalis Brand of Mesalamine, Oprea1_847633, SCHEMBL31297, 3amino-6-hydroxybenzoic acid, 5-amino-2-hydroxybenzoicacid, BSPBio_001058, KBioGR_002425, KBioSS_002431, 4-14-00-02058 (Beilstein Handbook Reference), KSC448C0L, MLS000758287, Novopharm Brand of Mesalamine, 5-Aminosalicylic acid, 95%, 5-Aminosalicylic acid, tablet, ARONIS23914, BIDD:GT0811, 3-amino-6-hydroxybenzoic acid, SmithKline Brand of Mesalamine, SPBio_002969, Yamanouchi Brand of Mesalamine, AC1Q51L9, BPBio1_001164, GTPL2700, ZINC1688, 5-Amino 2-hydroxy benzoic acid, DTXSID5024506, 5-Aminosalicylic acid, >=99%, 6291-36-7 (hydrochloride), BDBM60918, CTK3E8105, KBio2_002425, KBio2_004993, KBio2_007561, KBio3_002904, Salicylic acid, 5-amino-(8CI), cMAP_000045, MolPort-001-641-024, HMS1571E20, HMS2051M21, HMS2090I09, HMS2098E20, HMS3393M21, HMS3649K15, HMS3651M15, HMS3715E20, Pharmakon1600-01505993, Henning Berlin Brand of Mesalamine, BCP05326, GlaxoSmithKline Brand of Mesalamine, KS-00000CC5, KS-000048PQ, NSC38877, Schering Plough Brand of Mesalamine, Schering-Plough Brand of Mesalamine, Tox21_110384, Tox21_201610, Tox21_303125, 5-?Aminosalicylic Acid (Mesalazine), 5-Amino-2-hydroxybenzoic acid 97%, AN-874, ANW-39326, BBL013046, FC1035, MFCD00007877, NSC-38877, NSC759301, s1681, SBB052617, STK301678, Procter & Gamble Brand of Mesalamine, Sanofi Synthelabo Brand of Mesalamine, AKOS000118959, Tox21_110384_1, AC-2764, BCP9000175, CCG-100829, CS-2219, DB00244, HS-0100, LS-1894, LS11426, MCULE-5752745805, NC00079, NSC-759301, RP21708, RTR-032941, TRA0073805, NCGC00016344-01, NCGC00016344-02, NCGC00016344-04, NCGC00016344-05, NCGC00016344-07, NCGC00090934-01, NCGC00090934-02, NCGC00257142-01, NCGC00259159-01, 35589-28-7 (mono-hydrochloride salt), AJ-08068, BP-13074, BR-72925, CPD000145728, HY-15027, SAM001247020, SC-15695, 5-Aminosalicylic acid, analytical standard, AB1001921, KB-196569, KB-196728, ST2411704, ST4109571, TR-032941, A0317, AB00374979, AM20060091, FT-0619950, 1764-EP2272825A2, 1764-EP2275420A1, D00377, M-7246, 24215-EP2289518A1, 24215-EP2295053A1, 24215-EP2295409A1, 24215-EP2314574A1, 24215-EP2314590A1, 90701-EP2371811A2, AB00374979-09, AB00374979-10, AB00374979_11, AB00374979_12, 5-amino-2-hydroxybenzoic acid,5-Aminosalicylic acid, I06-0488, Q-201355, SR-01000763486-3, SR-01000763486-4, SR-01000763486-9, Z57127471, F1918-0003, 5-Amino-2-hydroxybenzoic acid; 5-AS; Mesalamine; 5-ASA, A3613/0153179, Mesalazine, European Pharmacopoeia (EP) Reference Standard, Mesalamine, United States Pharmacopeia (USP) Reference Standard, 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine, Mesalamine, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11, Mesalazine for system suitability, European Pharmacopoeia (EP) Reference Standard, 61513-32-4, SCHEMBL18038934